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pentose phosphate pathway; hexosemonophosphate shunt; NADPH; vascular smooth muscle; calcium; Rho kinase; protein kinase G; myosin phosphatase target subunit 1; vasodilator-stimulated phosphoprotein; phosphorylation GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD)-derived NADPH catalyzes reduction of oxidized (GSSG) to reduced (GSH) glutathione in all cell types, promotes nitric oxide synthesis in endothelial cells, and facilitates fatty acid synthesis in the liver (18, 40) . It has been proposed that the pentose phosphate pathway is also involved in glucose metabolism in vascular smooth muscle (VSM) (1) . Moreover, we (8) recently showed that G6PD is a novel regulator of VSM contractility. In that study, we demonstrated that G6PD is activated by membrane depolarization or by stimulation of receptor-mediated signaling pathways via protein kinase C (PKC). The activated G6PD elicits increases in intracellular free Ca 2ϩ ([Ca 2ϩ ] i ), thereby enhancing contraction of VSM. Conversely, inhibition of G6PD activity reduces [Ca 2ϩ ] i levels, thereby relaxing precontracted VSM (9) . The mechanism by which membrane depolarization activates PKC and G6PD and how inhibition of G6PD reduces [Ca 2ϩ ] i remain unclear, however. A variety of PKC isoforms are expressed in the coronary artery (CA), and we have shown that PKC␦ interacts with and activates G6PD by phosphorylating Ser210, near the catalytic domain, and that their interaction in CA is promoted by stimulation with KCl (8) . PKC␦ is activated by increases in diacylglycerol (DAG), but not by increases in [Ca 2ϩ ] i . We therefore suggest (Fig. 1 ) that PKC␦ and G6PD are activated by membrane depolarization in Ca 2ϩ -independent manner via the tumor suppressor enzyme phosphatase and tensin homologue deleted on chromosome 10 (PTEN), a major enzyme that dephosphorylates phosphatidylinositol (3,4,5)-trisphosphate (PIP 3 ) to phosphatidylinositol 4,5-bisphosphate (PIP 2 ) (29) and DAG pathway, which is increased by depolarization (17) , resulting in the stimulation of PKC activity. In the present study, therefore, we tested our hypothesis that G6PD activated by KCl via a PTEN-PKC pathway increases VSM contraction and that inhibition of G6PD relaxes smooth muscle by decreasing [ (14) . Although less information is available about the effects of membrane depolarization on Ca 2ϩ sequestration (SERCA) and extrusion (PMCA or NCX), it is known that inhibition of NCX increases the membrane potential and elevates [Ca 2ϩ ] i (22) . Therefore, as illustrated in a schematic (Fig. 1) , we speculated that inhibition of G6PD reduces Ca 2ϩ influx and facilitates the clearance of Ca 2ϩ through all three aforementioned mechanisms and Ca 2ϩ sensitivity to the myofilament. Our results show that G6PD inhibition relaxes CA mainly by reducing Ca 2ϩ influx and enhanc-ing Ca 2ϩ sequestration and in part through regulation of Rho kinase-dependent signaling pathways.
MATERIALS AND METHODS
The left anterior descending and circumflex CAs were harvested from bovine hearts purchased from a local slaughterhouse (Stuckey's Meat Packer, Semmes, AL). After the heart was quickly excised from the animal, it was placed in normal Tyrode solution (in mmol/l: 135 NaCl, 5.4 KCl, 1.8 CaCl 2, 1.0 MgCl2, 5 HEPES, and 11 glucose; pH was adjusted to 7.40 with NaOH) and transported to the laboratory on ice. Bovine CA smooth muscle cells (CASMCs) were purchased from Cell Application (San Diego, CA). All reagents were purchased from Sigma Chemical (St. Louis, MO), except the thromboxane analog (Z)-7-
heptan-6-yl}hept-5-enoic (U-46619), which was obtained from Cayman Chemical (Ann Arbor, MI).
Western blot analysis. Proteins were extracted from frozen tissue in lysis buffer after which Western blot analysis using the specific antibodies mentioned in RESULTS (see Figs. 2-9) was performed as described previously (10) .
G6PD activity. G6PD activity was measured in CA homogenates by following the reduction of NADP ϩ to NADPH (10) . NADPH fluorescence (excitation, 340 nm; emission, 460 nm) was detected using a Flx800 microplate with Synergy 2 fluorescence detectors (BioTek Instruments, Winooski, VT).
NADP(H) levels. The levels of NADP(H) in CA were determined by HPLC (Elite LaChrom Chromatography System; Hitachi, Tokyo, Japan) using previously published methods (10) .
PKC activity. Activation of PKC in CA smooth muscle was assessed using a non-radioactive assay kit purchased from Stressgen (Ann Arbor, MI). ELISA was performed as per the manufacturer's protocol, and activity was reported as antibodies per milligrams of protein.
[Ca 2ϩ ]i measurements. Changes in [Ca 2ϩ ]i levels in CA were determined using fura 3PE or Ca 2ϩ green (8) . To achieve a higher time resolution, changes in Ca 2ϩ fluorescence were determined based on excitation at a single wavelength and expressed as the ratio of the time-resolved fluorescence variation from the basal fluorescence (at 480 nm; F 480/520). [Ca 2ϩ ]i was also determined from the fura 3PE 340 nm/380 nm fluorescence ratio as previously described (8) .
Contraction of CA. Isolated, endothelium-denuded left anterior descending CA rings were prepared from bovine hearts and studied for changes in isometric force as described previously (8) . Low extracellular Na ϩ ([Na ϩ ]o) experiments were performed using previously published methods by replacing NaCl (120 mmol/l) with Nmethyl-D-glucamine (120 mmol/l) in Kreb's solution (22) .
Phosphorylation of myosin phosphatase target subunit 1 and myosin light chain. Phosphorylation of myosin phosphatase target subunit 1 (MYPT1) at Ser855, which is catalyzed by Rho kinase (37) , in CA was assessed by Western blot analysis using anti-phospho-MYPT1 antibodies (Cell Signaling). In addition, phosphorylation of myosin light chain (MLC) at Ser20 in CA was assessed as previously described (30) .
Vasodilator phosphoprotein phosphorylation. CAs were pretreated appropriately for each condition and homogenized. The tissue homogenate was subjected to Western blot analysis using anti-phosphovasodilator phosphoprotein (VASP) antibodies (Cell Signaling) to assess phosphorylation of VASP at Ser239 by PKG (3) .
Statistical analysis. Values are means Ϯ SE. ANOVA and post hoc Fisher's protected t-test were used for analysis in all studies of vascular contractility. All enzyme activity and Western blot data were analyzed using Student's t-tests. Values of P Ͻ 0.05 were considered significant. In all cases, the number of experimental determinations (n) was equal to the number of hearts from which CAs were harvested for this study.
RESULTS

Depolarization activates G6PD
. Consistent with our recent findings (8), we observed that G6PD is activated by membrane depolarization in CAs. G6PD assays ( Fig. 2A ) and enzyme kinetic analysis (Fig. 2B) showed that KCl (30 mmol/l)- Depolarization of VSM membrane results in activation of phospholipase C (PLC), which cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol trisphosphate (IP3). Of the cleaved products, DAG is important in activation of protein kinase C ␦ (PKC␦), which phosphorylates and activates G6PD. Activated G6PD then stimulates rise in intracellular calcium concentration ([Ca 2ϩ ]i) to induce contraction of VSM. As phosphatase and tensin homologue deleted on chromosome 10 (PTEN) dephosphorylates phosphatidylinositol (3,4,5)-trisphosphate (PIP3) to yield PIP2, we hypothesized that membrane depolarization activates PTEN to result in G6PD activation and contraction of VSM. Furthermore, pharmacological inhibition of G6PD by 6-aminonicotinamide (6AN) or epiandrosterone (EPI) is known to relax precontracted VSM. We, thus, questioned whether this is mediated by 1) increased Ca 2ϩ sequestration and extrusion, along with a concomitant decrease in Ca 2ϩ influx; and 2) inhibition of the Rho kinase pathway and activation of the protein kinase G (PKG) pathway, well-established mediators of vascular contraction and relaxation, respectively. PI3K, phosphotidylinositol 3-kinase.
induced membrane depolarization led to a doubling of V max , although K m was unaffected.
Depolarization stimulates PTEN signaling and activates G6PD via PKC. We recently observed that PKC␦ interacts with and activates G6PD (8). Here we examined possible upstream regulators of PKC involved in depolarization-induced activation of G6PD. Because PKC␦ requires DAG for its activation, our focus was on identifying the roles played by PTEN and phosphotidylinositol 3-kinase (PI3K), two key regulators of PIP 2 levels (29). We found that KCl activates PKC and that PKC was further activated by inhibition of PI3K using 2-morpholin-4-yl-8-phenylchromen-4-one (LY294002; 10 mol/l; Fig. 2C ). In addition, whereas phosphatase inhibitor cocktail 1 (PIC1; 10 mol/l; Sigma), a nonspecific serine-threonine phosphatase inhibitor, did not significantly affect KCl-induced increases in PKC activity, potassium bisperoxo(1,10-phenanthroline) oxovanadate V (Bpv; 10 mol/l; Calbiochem, CA), a specific inhibitor of PTEN (16), reduced PKC activity to a level comparable to that seen with KCl alone (Fig. 2C) . Similar changes in G6PD activity were observed when a phosphatase inhibitor was used in combination with KCl ( Fig.  2D ). Whereas PIC1 had no effect on KCl-induced increases in G6PD activity, phosphatase inhibitor cocktail 2 (PIC2; 10 mol/l; Sigma), a tyrosine phosphatase inhibitor, or Bpv blocked KCl-induced activation of G6PD. To then investigate the physiological effects of Bpv-induced inhibition of G6PD, we tested the effect of phosphatase inhibitors on CA contraction (Fig. 2E ). We found that PIC2 and Bpv attenuated KClinduced CA contractions.
G6PD inhibition leads to relaxation of CA precontracted with KCl. To investigate the mechanisms underlying G6PD-mediated vasoconstriction and the relaxation of precontracted vessels induced by G6PD inhibition, we next examined the effects of two structurally different G6PD inhibitors, 6-aminonicotinamide (6AN) and epiandrosterone (EPI). 6AN is an NADP ϩ analog widely used as an antineoplastic agent (23), while EPI is a 17-ketosteroid, the physiological function of which remains unknown. Enzyme kinetics analyses showed that treatment with 6AN and EPI altered V max and K m in ways characteristic of competitive and uncompetitive inhibitors, respectively (Fig. 3, A and B) . Given that G6PD reduces NADP ϩ to NADPH, we further confirmed the effectiveness of 6AN and EPI by examined their effects on the NADPH-to-NADP ϩ ratio. As expected, both inhibitors significantly reduced the NADPHto-NADP ϩ ratio (0.30 Ϯ 0.07 and 0.42 Ϯ 0.12, respectively), compared with untreated time-matched controls (2.44 Ϯ 0.82). Moreover, when 6AN or EPI was applied to CAs precontracted with KCl, both were able to induce relaxation (Fig. 3, C and  D) , and this is consistent with our previous findings (9) .
Aortic relaxation induced by inhibition of G6PD is attenuated in G6PD-deficient mice. To determine whether the apparent regulation of CA contractility by G6PD is unique to bovine species, we used genetically mutated G6PD-deficient mice to examine the effects of G6PD inhibitors on precontracted aortas. We first established the utility of this model for our application by characterizing G6PD activity levels in homogenates of heart from the mice (Fig. 4A) . In heart, both G6PD ). When aortas from G6PD ϩ/ϩ and G6PD Ϫ/Ϫ mice were then used to assess the effect of G6PD inhibitors on vessels precontracted with KCl, we found that ϩ (B; n ϭ 10). C: KCl (30 mmol/l; n ϭ 10) increased PKC activity, compared with time-matched controls (n ϭ 10). The response was increased by the PI3K inhibitor LY294002 (10 mol/l; n ϭ 8) and reduced by the PTEN inhibitor bisproxo(pyridine-2-carboxyl)oxovanadate (Bpv; 10 mol/l; n ϭ 8) but not by the serine-threonine phosphatase inhibitor cocktail 1 (PIC1; 10 mol/l; n ϭ 5). D: KCl (30 mmol/l; n ϭ 25) increased G6PD activity, compared with time-matched controls. The response was unaffected by PIC1 (10 mol/l; n ϭ 8) but was reduced the tyrosine phosphatase inhibitor PIC2 (10 mol/l; n ϭ 5) or Bpv (10 mol/l; n ϭ 8). E: pretreatment with PIC2 (10 mol/l; n ϭ 12) or Bpv (10 mol/l; n ϭ 12) significantly reduced KCl (30 mmol/l; n ϭ 12)-induced CA contraction. S, substrate; Vi, initial velocity; ABS, antibodies. both 6AN and EPI dose dependently relaxed precontracted aortas from G6PD ϩ/ϩ mice (Fig. 4B ), as they did with bovine CA (Fig. 3C) . By contrast, 6AN (1 mmol/l)-induced relaxation was reduced by 74.6% in precontracted aortas from G6PD Ϫ/Ϫ mice, compared with G6PD ϩ/ϩ mice (Fig. 4C) , while EPI (100 mol/l)-induced relaxation was inhibited to a similar degree (Fig. 4D) .
Inhibition of G6PD attenuates depolarization-induced phosphorylation of MLC. We next investigated the effect of 6AN and EPI on depolarization-induced increases in [Ca 2ϩ ] i and MLC phosphorylation. Our data show that in isolated CASMCs depolarization increased [Ca 2ϩ ] i from 80 to 150 nmol/l, and that this effect was significantly attenuated by EPI (100 mol/l; Fig. 5A ). Consistently, 6AN (1 mmol/l; Fig. 5B ) also decreased KCl-induced elevation of [Ca 2ϩ ] i in freshly isolated CA rings. As Ca 2ϩ -dependent phosphorylation of MLC is a key step in excitation-contraction coupling in VSM, we used Western analysis to test whether G6PD inhibition alters levels of p-MLC (Fig. 5C ). We found that depolarization increased p-MLC levels, compared with untreated controls, and that the effect was completely abolished under Ca 2ϩ -free conditions. The depolarization-induced increase in p-MLC was also re- 
(n ϭ 3-4), and G6PD Ϫ/Ϫ (n ϭ 7-8) hearts. B: 6AN (n ϭ 7) and EPI (n ϭ 4) dose dependently relaxed aorta from G6PD ϩ/ϩ (wild-type) precontracted with KCl (30 mmol/l). C and D: 6AN (1 mmol/l) and EPI (100 mol/l) induced less relaxation of aorta isolated from G6PD Ϫ/Ϫ mice (G6PDmut; n ϭ 6 -9) than wild-type mice (n ϭ 4 -7).
duced by 6AN, which brought p-MLC levels down to those seen in the untreated control.
NCX and SERCA are activated during depolarization-induced CA contraction but PMCA is not. [Ca 2ϩ ] i is regulated by three major mechanisms: Ca 2ϩ influx, extrusion, and sequestration. We selectively inhibited different Ca 2ϩ pumps to investigate which of these mechanisms are activated during depolarization-induced CA contraction. KCl-induced CA contractions were unaffected by inhibition of PMCA with caloxin (AnaSpec; 10 mol/l; Fig. 6A ), but reducing [Na ϩ ] o or inhibiting SERCA with cyclopiazonic acid (CPA; 200 mol/l) elicited a doubling of contractile force (Fig. 6A) . To confirm the effectiveness of the Ca 2ϩ pump inhibitors, we tested the effects of caloxin and CPA on U46619-induced CA contractions. Figure 6B shows that U46619 (100 nmol/l)-induced CA contractions were augmented by PMCA or SERCA inhibition, confirming the efficacy of these inhibitors at the respective doses used in our experiments.
G6PD inhibitors relax depolarization-induced CA contractions by increasing Ca 2ϩ sequestration and reducing influx. To assess their involvement in 6AN-induced relaxation of precontracted CA, we tested the effect of selectively inhibiting different Ca 2ϩ pumps on this relaxation (Fig. 6C) . We found that inhibiting SERCA with CPA reduced 6AN-induced relaxation, while reducing [Na ϩ ] o unexpectedly accelerated CA relaxation. Inhibiting PMCA with caloxin had no effect on 6AN-induced relaxation.
Reverse mode Na ϩ /Ca 2ϩ exchange activates SERCA to regulate CA contraction and relaxation. To study the role of Ca 2ϩ extrusion during 6AN-induced relaxation of precontracted CA, we first assessed the effect of low [Na ϩ ] o on G6PD (14) . Consistent with those observations, we found that incubating CAs in low [Na ϩ ] o Kreb's solution evoked contractions (2.5-3.0 g), though they were weaker than contractions induced by KCl (Fig. 7A) . When CAs were treated with KCl (30 mmol/l) in low [Na ϩ ] o solution, the evoked contractions were about twice as strong as those evoked by KCl alone (Fig. 7A) . Inhibition of SERCA in low [Na ϩ ] o solution induced contractions similar to those induced by KCl (Fig. 7A) .
We recently demonstrated that activation of G6PD by membrane depolarization increases [Ca 2ϩ ] i and induces CA contraction (8 (Fig. 7, C and D) . (Fig. 8B) . KCl treatment increased phosphorylation of MYPT1 at Ser855, which was blocked by 6AN (Fig. 8, C and D) . On the other hand, there was no significant difference between contractions evoked by 30 mmol/l KCl under control conditions and in the presence of the specific PKG inhibitor 8-bromo-␤-phenyl-1,N 2 -ethenoguanosine-3=,5=-cyclic monophosphorothioate, Rp-isomer (Rp-8-Br-PET-cGMPs; BioLog, Bremen, Germany; 100 nmol/l; Fig. 9A ). As expected, inhibition of PKG reduced CA relaxation induced by sodium nitroprusside, a nitric oxide donor (Fig. 9B) , but surprisingly PKG inhibition enhanced CA relaxation evoked by 6AN (Fig. 9C) , although 6AN increased phosphorylation of VASP at Ser239, compared with untreated and KCl-treated CA. This effect was blocked by Rp-8-Br-PETcGMPs or staurosporine (Fig. 9, D and E) . DISCUSSION We previously showed that membrane depolarization activates PKC␦, which mediates KCl-induced activation of G6PD in isolated CA (8) . Our present findings show that pretreating CAs with Bpv, a PTEN inhibitor, reduces KCl-stimulated increases in PKC and G6PD activity and that it also inhibits KCl-induced CA contraction. In addition, we provide evidence that inhibiting G6PD reduces KCl-induced CA contraction by reducing Rho kinase-mediated phosphorylation of MYPT1 and MLC and that activation of PKG does not contribute to the VSM relaxation evoked by 6AN. Our data thus suggest a novel role for PTEN and G6PD in regulating VSM tone.
Rho kinase but not PKG mediates 6-AN-induced relaxation
PI3K and PTEN are expressed in all mammalian cells, including VSMCs, and are involved in regulating VSM contraction evoked by KCl or electrical stimulation (31, 33) . PTEN is a dual phosphatase that dephosphorylates PIP 3 to PIP 2 , which is in turn cleaved to IP 3 and DAG by phospholipase C. Both of these products are second messengers, and DAG is well known to activate various PKC isoforms in VSM. We found that Bpv inhibited KCl-evoked increases in PKC and G6PD activity in CA. By contrast, KCl-evoked PKC activity in CA was enhanced by inhibition of PI3K, which suggests KCl-evoked increases in PIP 2 are responsible for stimulating Fig. 7 . Effect of low [Na ϩ ]o on CA contraction, G6PD activity, and 6AN-evoked relaxation. A: reducing [Na ϩ ]o from 143 to 23 mmol/l (low Na ϩ ; n ϭ 10) induced contractions of CA that were increased by KCl (30 mmol/l; Na ϩ -free ϩ 30K; n ϭ 10) or CPA (200 mol/; Na ϩ -free ϩ CPA; n ϭ 7). B: low [Na ϩ ]o (low Na ϩ ) also increased G6PD activity in CAs, and KCl (low Na ϩ ϩ 30K) or CPA (low Na ϩ ϩ CPA) further enhanced the activity (n ϭ 7 in each group). C: 6AN dose dependently relaxed CAs precontracted with low Na ϩ ϩ 30K or low Na ϩ ϩ CPA. D: time course of 6AN (1 mmol/l)-induced relaxation of CAs precontracted with low Na ϩ ϩ CPA (n ϭ 8) and low Na ϩ ϩ 30K (n ϭ 10). Relaxation of CAs precontracted with low Na ϩ ϩ CPA was accelerated slightly, compared with CAs contracted with low Na ϩ ϩ 30K (n ϭ 8 -10). *P Ͻ 0.05 vs. KCl in A, vs. control in B, and vs. low Na ϩ ϩ 30K in C; @P Ͻ 0.05 vs. control in B and time 0 in D.
PKC activity. The precise mechanism via which depolarization induces activation of PTEN was not investigated in the present study; however, PTEN is known to be activated by phosphorylation/dephosphorylation of its COOH-terminal region, which serves as an electrostatic switch in controlling the membrane translocation of the protein (5) or by phosphorylation in a putative S/TX(X)TB motif by Rho kinase during cell chemotaxis (19, 36) . That said, Rho kinase-dependent phosphorylation is unlikely to activate PTEN or PKC-dependent G6PD activity, as the Rho kinase inhibitor Y27632 does not affect KCl-induced PKC and G6PD activation in CA (8) . Alternatively, PTEN activation by KCl or membrane depolarization could result from PIP 2 acting as a feedback activator (4). In addition, PTEN is predominantly cytosolic and lacks the fourtransmembrane voltage-sensor domain characteristic of voltage-gated ion channels (24) , which makes it unlikely that Fig. 9 . PKG does not participate in 6AN-induced CA relaxation. Rp-8-Br-PET-cGMPs (100 nmol/l), a PKG inhibitor, increased (NS; n ϭ 10) KCl (30 mmol/l)-induced contraction of CAs (A) and reduced (P Ͻ 0.05; n ϭ 10) relaxation induced by a nitric oxide donor, sodium nitroprusside (SNP; B). C: Rp-8-Br-PET-cGMPs (100 nmol/l) paradoxically increased 6AN-induced relaxation of CAs precontracted with KCl (n ϭ 10 -15). D and E: Western blot analysis using anti-phospho-vasodilator-stimulated phosphoprotein (VASP) and anti-VASP showing the effects of Rp-8-Br-PET-cGMPs (cGMPs; 100 nmol/l) and staurosporine (Stau; 10 nmol/l) on phosphorylation of VASP at Ser239, a PKG-specific phosphorylation site. Blot shown is representative blot of 5 experiments. Note: samples were loaded on 2 gels in blinded fashion. 30K ϩ 6AN; 30K ϩ 6AN ϩ cGMPs and 30K ϩ 6AN ϩ stau were loaded on gel #1. 30K-treated control and time-match control loaded on a separate gel (gel #2) were combined in final blot figure demonstrated in D. A space in between lanes indicates 2 blots were combined. Also, original captures of gel pictures were flipped to get left to right orientation. The information or the samples in other lanes on gel #1 and #2 not relevant to this study were not used. *P Ͻ 0.05 vs. control; @P Ͻ 0.05 vs. 30K. PTEN functions as a membrane voltage-sensing protein and implies the existence of other voltage-sensing proteins that initiate the signaling cascade to stimulate PTEN. For instance, the striking sequence homology between the catalytic domains of PTEN and VSP, a novel voltage-sensing non-ion channel protein identified in Ciona intestinalis, is noteworthy (24) . Moreover, a Zebrafish ortholog of voltage sensing protein (VSP) was recently shown to have both voltage-sensing and tyrosine phosphatase capabilities (13) . Given our findings, we cannot exclude the possibility that an as yet unidentified mammalian VSP was activated by depolarization. Consistent with this notion, our results indicate that Bpv and the tyrosine phosphatase inhibitor PIC2 each inhibited KCl-induced CA contraction.
Depolarization of VSMCs causes rapid Ca 2ϩ influx through L-type voltage-gated channels with subsequent activation of MLC kinase and a Rho-Rho kinase pathway that mediates an increase in the Ca 2ϩ sensitivity of the contractile proteins. The Ca 2ϩ sensitization primarily involves phosphorylation of MLC by Ca 2ϩ -calmodulin-activated MLC kinase and is negatively regulated by the cyclic nucleotide-dependent kinases PKA and PKG. It is known that MLC is also phosphorylated in a Ca 2ϩ -independent manner (12) . In the present study, incubation of CAs under extracellular [Ca 2ϩ ]-free conditions completely inhibited KCl-evoked MLC phosphorylation, which suggests MLC phosphorylation is dependent on either the entry of extracellular Ca 2ϩ and/or release of stored Ca 2ϩ from the SR. In addition, we recently observed that depolarization induced Ca 2ϩ -independent activation of G6PD mediated by PKC␦ increases CA contractility (8) . Consistent with that report, we observed in the present study that the increase in [Ca 2ϩ ] i in CA and CASMCs following their depolarization can be significantly attenuated by 6AN or EPI and that 6AN nearly completely blocks KCl-induced phosphorylation of MLC in CA. These data support the idea that depolarization-induced, Ca 2ϩ -independent activation of G6PD is at least partly responsible for the increase in [Ca 2ϩ ] i and the Ca 2ϩ -dependent steps involved in VSMC contraction, including the increased Ca 2ϩ sensitivity of the myofilaments.
The mechanisms by which Ca 2ϩ is handled in VSM are not fully understood but are known to involve a variety of Ca 2ϩ channels and transporters. One Ca 2ϩ transporter involved is the NCX, which transports Na ϩ and Ca 2ϩ into or out of cells, depending on the extracellular and intracellular concentrations of the two cations. In reverse mode, it pumps Na ϩ out of and Ca 2ϩ into the cells (14) . It has been speculated that the NCX operating in reversed mode contributes to the generation of myogenic tone and the maintenance of blood pressure (22) . Our results show that decreasing extracellular Na ϩ , which forces the NCX to operate in the reverse mode, is sufficient to substantially increase G6PD activity and CA contraction. Reverse-mode Na ϩ /Ca 2ϩ exchange also augments depolarization-induced CA contractions, supporting the idea that it is important for generation of smooth muscle tone (28, 39) .
Our results are consistent with earlier observations indicating forward mode of Na ϩ /Ca 2ϩ exchange is involved in clearing Ca 2ϩ from the cytoplasm (22, 28) . We also found that inducing reverse-mode Na ϩ /Ca 2ϩ exchange favors VSM membrane depolarization and Ca 2ϩ entry and that inhibition of SERCA using CPA further increases both depolarization-and NCX-induced CA contraction. This finding is consistent with the earlier observations that CPA augments KCl-induced peak and sustained tension, as well as increases in [ into the SR. We found that PMCA inhibition had no effect on either depolarization-induced contractile force or 6AN-induced relaxation of CAs precontracted with KCl. This suggests that PMCA is not involved in the development of contractile force or modulating relaxation in precontracted CA under the conditions tested in this study. Consistent with that idea, PMCA4 gene ablation had no significant effect on KCl-induced peak contractions in urinary bladder (21) . On the other hand, the rate of KCl-induced contraction was significantly diminished in PMCA4 gene ablated bladder, and the time constant for its relaxation in Ca 2ϩ -free solution showed a marginal but significant increase. Therefore, a role for PMCA in modulating the rate of depolarization-induced contraction cannot be ruled out completely, although our data indicate that Ca 2ϩ extrusion via Na ϩ /Ca 2ϩ exchange and sequestration by SERCA are likely the important mechanisms for maintaining appropriate [Ca 2ϩ ] i levels during depolarization-induced contraction of CA.
Our investigation into downstream effectors of G6PD revealed that phosphorylation of MYPT1 at Ser855, a target of Rho kinase (37) , was increased and phosphorylation of VASP at Ser239 (3), a target of PKG, was slightly decreased by KCl-induced depolarization. Upon inhibition of G6PD in CA precontracted with KCl, MYPT1 phosphorylation decreased and VASP phosphorylation increased, which suggests both of these kinases are affected by inhibition by G6PD. Consistent with that idea, the activities of both Rho kinase and PKG are increased by oxidization of NADPH to NADP ϩ or by increased NADPH-dependent H 2 O 2 generation (2, 11, 26, 27) .
It is well known that activation of Rho kinase increases VSM contraction (12) and PKG promotes its relaxation (20) . Consistent with that finding, inhibition of Rho kinase by Y27632 reduced KCl-induced CA contraction, as well as 6AN-induced relaxation of CA precontracted with KCl. To our surprise, however, inhibition of PKG by Rp-8-Br-PET-cGMPs reduced 6AN-induced VASP phosphorylation, while 6AN-evoked relaxation was enhanced and the dose-response curve was shifted to the left. It has been proposed that PKG phosphorylates VASP and that this is important for the regulation of actin cytoskeletal dynamics (15) . Among proteins inactivated by PKG-dependent phosphorylation is Rho A (25), which activates Rho kinase and increases VSM contraction (34) . In this way, the actions of PKG oppose those of Rho kinase in VSM. It remains unclear why inhibition of Rho kinase and PKG should, respectively, decrease and increase 6AN-induced CA relaxation. However, our findings suggest that changes in cellular redox associated with G6PD inhibition reduce Rho kinase-dependent phosphorylation of MYPT1 and, in turn, contraction of CA and that increases in PKG activation due to G6PD-inhibition may not play a major role in regulating vasomotor function.
In summary, our present study looking into the molecular mechanisms involved in depolarization-induced activation of G6PD and subsequent contraction of CA found that 1) PTEN mediates depolarization-induced activation of PKC and G6PD; 2) G6PD-inhibition-induced relaxation of CA is mediated by inhibition of Ca 2ϩ influx and enhanced Ca 2ϩ sequestration into the SR but not by altered Ca 2ϩ extrusion through either the PMCA or NCX; 3) G6PD inhibition reduces the Ca 2ϩ sensitivity of myofilaments, perhaps through reduction in Rho kinase activity and MYPT1 phosphorylation; and 4) Rho kinase and PKG are regulated by G6PD-inhibition. Therefore, as proposed in a schematic illustration (Fig. 10) , increase in G6PD activity, which modulates intracellular redox, by depolarization of the membrane potential via a PTEN-PKC pathway plays a physiological role in increasing [Ca 2ϩ ] i , Ca 2ϩ sensitivity to the myofilament, and contractility. Conversely, G6PD inhibition relaxes CA by decreasing Ca 2ϩ influx, increasing Ca 2ϩ sequestration, and inhibiting Rho kinase but not by increasing Ca 2ϩ extrusion or activating PKG.
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